___________________________________________________________________________________________________ Pete
Pharma
Scaling adoption
Marc does not view pharmaceutical 3D printing as a distant prospect. He believes it will become mainstream.“ Over the next five years, I believe pharmaceutical 3D printing will move beyond the early adopter phase and become a standard tool for many compounding pharmacies.” Marc predicts it will change how compounding pharmacies operate daily. Instead of relying on manual labor, partners can use equipment that scales according to demand.“ Instead of having ten people making things by hand, you will have ten 3D printers managed by one person, moving production closer to the point of care.” The transition to 3D printing in pharmaceutical compounding will not happen overnight. Technology is already in place, and early adopters are beginning to embrace it.“ As with any innovation, adoption follows a pattern. Those who are willing to move first are already looking ahead, while others will follow as the benefits become clearer. As the landscape continues to evolve, broader acceptance will come, with the wider market increasingly viewing 3D printing as part of standard practice,” he reflects.
For Marc, the goal has never been simply to sell another piece of equipment. It’ s to fundamentally change how compounded medicines are made.
That requires taking risks, challenging conventional thinking, and continually asking what could be done better.
“ You miss every shot you don’ t take,” Marc says.
For Pete Pharma, that shot is already changing the future of pharmaceutical compounding. ■
www. petepharma. com
americanhealthcareleader. com 85